Pepke-Zaba J - Search Results

1

Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension.

Suntharalingam J, Goldsmith K, van Marion V, Long L, Treacy CM, Dudbridge F, Toshner MR, Pepke-Zaba J, Eikenboom JC, Morrell NW. Suntharalingam J, et al. Eur Respir J. 2008 Apr;31(4):736-41. doi: 10.1183/09031936.00055107. Epub 2007 Dec 5. Eur Respir J. 2008. PMID: 18057060 Free article.

2

Atrial natriuretic peptide in primary pulmonary hypertension.

Morice AH, Pepke-Zaba J, Brown MJ, Thomas PS, Higenbottam TW. Morice AH, et al. Eur Respir J. 1990 Sep;3(8):910-3. Eur Respir J. 1990. PMID: 2149841

3

Pulmonary hypertension in patients with COPD: NO treatment?

Pepke-Zaba J, Morrell NW. Pepke-Zaba J, et al. Thorax. 2003 Apr;58(4):283-4. doi: 10.1136/thorax.58.4.283. Thorax. 2003. PMID: 12668784 Free PMC article. No abstract available.

4

The endothelin system and its role in pulmonary arterial hypertension (PAH).

Pepke-Zaba J, Morrell NW. Pepke-Zaba J, et al. Thorax. 2005 Jun;60(6):443-4. doi: 10.1136/thx.2004.031724. Thorax. 2005. PMID: 15923241 Free PMC article. No abstract available.

5

Large granular lymphocyte leukaemia: a curable form of pulmonary arterial hypertension [corrected].

Howard LS, Chatterji S, Morrell NW, Pepke-Zaba J, Exley AR. Howard LS, et al. Hosp Med. 2005 Jun;66(6):364-5. doi: 10.12968/hmed.2005.66.6.18407. Hosp Med. 2005. PMID: 15974171 No abstract available.

6

Bosentan in inoperable chronic thromboembolic pulmonary hypertension.

Hughes R, George P, Parameshwar J, Cafferty F, Dunning J, Morrell NW, Pepke-Zaba J. Hughes R, et al. Thorax. 2005 Aug;60(8):707. doi: 10.1136/thx.2005.046961. Thorax. 2005. PMID: 16061720 Free PMC article. No abstract available.

7

The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study.

Hughes RJ, Jais X, Bonderman D, Suntharalingam J, Humbert M, Lang I, Simonneau G, Pepke-Zaba J. Hughes RJ, et al. Eur Respir J. 2006 Jul;28(1):138-43. doi: 10.1183/09031936.06.00135905. Epub 2006 Apr 12. Eur Respir J. 2006. PMID: 16611652 Free article.

8

Does rapid dose titration affect the hepatic safety profile of Bosentan?

Suntharalingam J, Hodgkins D, Cafferty FH, Hughes RJ, Pepke-Zaba J. Suntharalingam J, et al. Vascul Pharmacol. 2006 Jun;44(6):508-12. doi: 10.1016/j.vph.2006.03.004. Epub 2006 May 19. Vascul Pharmacol. 2006. PMID: 16713365 Clinical Trial.

9

Current understanding of the role of bosentan in inoperable chronic thromboembolic pulmonary hypertension.

Hughes R, Jais X, Suntharalingam J, Humbert M, Parent F, Simonneau G, Pepke-Zaba J. Hughes R, et al. Expert Opin Pharmacother. 2006 Jun;7(9):1133-8. doi: 10.1517/14656566.7.9.1133. Expert Opin Pharmacother. 2006. PMID: 16732700 Review.

10

Effects of nebulised iloprost on pulmonary function and gas exchange in severe pulmonary hypertension.

Reichenberger F, Mainwood A, Doughty N, Fineberg A, Morrell NW, Pepke-Zaba J. Reichenberger F, et al. Respir Med. 2007 Feb;101(2):217-22. doi: 10.1016/j.rmed.2006.05.019. Epub 2006 Jul 10. Respir Med. 2007. PMID: 16831539 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters